期刊
CHEMICAL SOCIETY REVIEWS
卷 47, 期 2, 页码 514-532出版社
ROYAL SOC CHEMISTRY
DOI: 10.1039/c7cs00550d
关键词
-
资金
- FCT-Fundacao para a Ciencia e a Tecnologia (CQM, Portuguese Government funds) [Pest-OE/QUI/UI0674/2013]
- Associacao Regional para o Desenvolvimento da Investigacao Tecnologia e Inovacao (ARDITI) [M1420-01-0145-FEDER-000005, Madeira 14-20]
- CNRS, France
- Science and Technology Commission of Shanghai Municipality [17540712000]
For the first time, an overview of dendrimers in combination with natural products and analogues as anti-cancer agents is presented. This reflects the development of drug delivery systems, such as dendrimers, to tackle cancers. The most significant advantages of using dendrimers in nanomedicine are their high biocompatibility, good water solubility, and their entry - with or without encapsulated, complexed or conjugated drugs - through an endocytosis process. This strategy has accelerated over the years in order to develop nanosystems as nanocarriers, to decrease the intrinsic toxicity of anti-cancer agents, to decrease the drug side effects, to increase the efficacy of the treatment, and consequently to improve patient compliance.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据